Valeritas Holdings, Inc. (VLRX): Price and Financial Metrics
VLRX Stock Summary
- VLRX has a higher market value than just 2.48% of US stocks; more precisely, its current market capitalization is $5,607,102.
- VLRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 96.08% of US stocks.
- NA's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -783.9%, greater than the shareholder yield of merely 0.7% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to NA are JKS, ELGX, SPNE, HEAR, and STRI.
VLRX Stock Price Chart Interactive Chart >
VLRX Price/Volume Stats
|Current price||$0.26||52-week high||$11.39|
|Prev. close||$0.28||52-week low||$0.25|
|Day high||$0.32||Avg. volume||694,630|
|50-day MA||$0.81||Dividend yield||N/A|
|200-day MA||$2.05||Market Cap||2.17M|
Valeritas Holdings, Inc. (VLRX) Company Bio
Valeritas Holdings, a commercial-stage medical technology company, focuses on developing technologies to treat patients with Type 2 diabetes. It offers V-Go, a disposable insulin delivery device for basal-bolus therapy. The company was founded in 2006 and is based in Bridgewater, New Jersey.